Stay informed with the latest industry insights from Tufts CSDD. Explore our collection of press releases, addressing critical topics and emerging trends that shape the future of drug development and innovation.
October 2024
How to Measure ROI in Decentralized Clinical Trials | Clinical Trial Vanguard
DPHARM 2024 Highlights ClinOps Innovations That Address Cost, Complexity, & Capabilities | Clinical Leader
September 2024
Examining Short and Long-Term ROI of DCT Deployments | Applied Clinical Trials
Description: Ken Getz, Executive Director and Research Professor, shares insights on DCT deployments at the DPharm 2024 conference. Nicholas Saraceno, ACT Editor, summarizes Ken’s presentation on the ROI of DCT deployments, organizational techniques for clinical trial planning and execution, and insights from the PACT Consortium. Access the full article here: https://www.appliedclinicaltrialsonline.com/view/analyzing-dct-deployments
The Relationship Between Participant Diversity and DCT Use in Clinical Trials | Applied Clinical Trials
Description: FDA issued a draft guidance as part of the agency’s efforts to advance innovations in clinical trial design and conduct which, when finalized, will support the conduct of randomized controlled trials with streamlined protocols and procedures that focus on essential data collection, allowing integration of research into routine clinical practice. This may improve convenience and accessibility for participants and allow for enrollment of more representative populations, resulting in more generalizable trial results. Learn more about the FDA Guidance here: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/integrating-randomized-controlled-trials-drug-and-biological-products-routine-clinical-practice
July 2024
Decentralized Clinical Trials: A New Era of Diversity | Clinical Trial Vanguard
June 2024
March 2024
The Rise, Fall, and Eventual Rebound of DCTs | Clinical Leader
June 2023
Optimizing the Process for Adopting DCT Solutions | Applied Clinical Trials
October 2022
Will DCTs Become the Norm | Clinical Leader
September 2022
Adapting Site Selection for Clinical Trial Decentralization and the Future Landscape | Applied Clinical Trials
July 2022
Decentralized Clinical Trials, Patient Experience and the Role of Supply Chain Management | Fierce Pharma
New Data Reveals DCTs Yield Better Clinical Trial ROI | Applied Clinical Trials
January 2022
Tufts Links Decentralized Clinical Trials to Shorter Cycle Time, Cost Savings | Outsourcing Pharma
Not Just for a Pandemic: Decentralized Clinical Trials Pay Off Financially, Study Finds | Fierce Biotech